TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Equine Influenza Vaccine Market Report & Forecast 2022-2028

Global and United States Equine Influenza Vaccine Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 23 September 2022
  • Pages :72
  • Formats:
  • Report Code:SMR-7383850
OfferClick for best price

Best Price: $2393

Market Analysis and Insights: Global Equine Influenza Vaccine Market

The global Equine Influenza Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Equine Influenza Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Equine Influenza Vaccine market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Equine Influenza Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Equine Influenza Vaccine market.

Global Equine Influenza Vaccine Scope and Market Size

Equine Influenza Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Equine Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Equine Influenza Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Liquid
Powder
Segment by Application
Home
Pet Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Equine Influenza Vaccine product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Equine Influenza Vaccine, with price, sales, revenue, and global market share of Equine Influenza Vaccine from 2019 to 2022.

Chapter 3, the Equine Influenza Vaccine competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Equine Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Equine Influenza Vaccine market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Equine Influenza Vaccine.

Chapter 13, 14, and 15, to describe Equine Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Equine Influenza Vaccine Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Study Coverage
1.1 Equine Influenza Vaccine Product Introduction
1.2 Global Equine Influenza Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Equine Influenza Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Equine Influenza Vaccine Sales in Volume for the Year 2017-2028
1.3 United States Equine Influenza Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Equine Influenza Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Equine Influenza Vaccine Sales in Volume for the Year 2017-2028
1.4 Equine Influenza Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Equine Influenza Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Equine Influenza Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Equine Influenza Vaccine Market Dynamics
1.5.1 Equine Influenza Vaccine Industry Trends
1.5.2 Equine Influenza Vaccine Market Drivers
1.5.3 Equine Influenza Vaccine Market Challenges
1.5.4 Equine Influenza Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Equine Influenza Vaccine Market Segment by Type
2.1.1 Liquid
2.1.2 Powder
2.2 Global Equine Influenza Vaccine Market Size by Type
2.2.1 Global Equine Influenza Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Equine Influenza Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Equine Influenza Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Equine Influenza Vaccine Market Size by Type
2.3.1 United States Equine Influenza Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Equine Influenza Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Equine Influenza Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Equine Influenza Vaccine Market Segment by Application
3.1.1 Home
3.1.2 Pet Clinic
3.1.3 Others
3.2 Global Equine Influenza Vaccine Market Size by Application
3.2.1 Global Equine Influenza Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Equine Influenza Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Equine Influenza Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Equine Influenza Vaccine Market Size by Application
3.3.1 United States Equine Influenza Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Equine Influenza Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Equine Influenza Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Equine Influenza Vaccine Competitor Landscape by Company
4.1 Global Equine Influenza Vaccine Market Size by Company
4.1.1 Top Global Equine Influenza Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Equine Influenza Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global Equine Influenza Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global Equine Influenza Vaccine Price by Manufacturer (2017-2022)
4.2 Global Equine Influenza Vaccine Concentration Ratio (CR)
4.2.1 Equine Influenza Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Equine Influenza Vaccine in 2021
4.2.3 Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Equine Influenza Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global Equine Influenza Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Equine Influenza Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into Equine Influenza Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Equine Influenza Vaccine Market Size by Company
4.5.1 Top Equine Influenza Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Equine Influenza Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Equine Influenza Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Equine Influenza Vaccine Market Size by Region
5.1 Global Equine Influenza Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Equine Influenza Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Equine Influenza Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Equine Influenza Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Equine Influenza Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Equine Influenza Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Equine Influenza Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Equine Influenza Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Equine Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Equine Influenza Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Equine Influenza Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Equine Influenza Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Equine Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Equine Influenza Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Equine Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Equine Influenza Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Equine Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Corporation Information
7.1.2 Zoetis Description and Business Overview
7.1.3 Zoetis Equine Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Zoetis Equine Influenza Vaccine Products Offered
7.1.5 Zoetis Recent Development
7.2 Merck Animal Health
7.2.1 Merck Animal Health Corporation Information
7.2.2 Merck Animal Health Description and Business Overview
7.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Animal Health Equine Influenza Vaccine Products Offered
7.2.5 Merck Animal Health Recent Development
7.3 Boehringer Ingelheim Vetmedica
7.3.1 Boehringer Ingelheim Vetmedica Corporation Information
7.3.2 Boehringer Ingelheim Vetmedica Description and Business Overview
7.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Products Offered
7.3.5 Boehringer Ingelheim Vetmedica Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Equine Influenza Vaccine Industry Chain Analysis
8.2 Equine Influenza Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Equine Influenza Vaccine Distributors
8.3 Equine Influenza Vaccine Production Mode & Process
8.4 Equine Influenza Vaccine Sales and Marketing
8.4.1 Equine Influenza Vaccine Sales Channels
8.4.2 Equine Influenza Vaccine Distributors
8.5 Equine Influenza Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Equine Influenza Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Equine Influenza Vaccine Market Trends
Table 3. Equine Influenza Vaccine Market Drivers
Table 4. Equine Influenza Vaccine Market Challenges
Table 5. Equine Influenza Vaccine Market Restraints
Table 6. Global Equine Influenza Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Equine Influenza Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Equine Influenza Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Equine Influenza Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Equine Influenza Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Equine Influenza Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Equine Influenza Vaccine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Equine Influenza Vaccine Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Equine Influenza Vaccine Sales Share by Manufacturer, 2017-2022
Table 15. Global Equine Influenza Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Influenza Vaccine as of 2021)
Table 18. Top Players of Equine Influenza Vaccine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Equine Influenza Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Equine Influenza Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Equine Influenza Vaccine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Equine Influenza Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Equine Influenza Vaccine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Equine Influenza Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Equine Influenza Vaccine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Equine Influenza Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Equine Influenza Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Equine Influenza Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Equine Influenza Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Equine Influenza Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Equine Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Equine Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Equine Influenza Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Equine Influenza Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Equine Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Equine Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Equine Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Equine Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Equine Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Equine Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Zoetis Corporation Information
Table 43. Zoetis Description and Business Overview
Table 44. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Zoetis Equine Influenza Vaccine Product
Table 46. Zoetis Recent Development
Table 47. Merck Animal Health Corporation Information
Table 48. Merck Animal Health Description and Business Overview
Table 49. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Merck Animal Health Product
Table 51. Merck Animal Health Recent Development
Table 52. Boehringer Ingelheim Vetmedica Corporation Information
Table 53. Boehringer Ingelheim Vetmedica Description and Business Overview
Table 54. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Boehringer Ingelheim Vetmedica Product
Table 56. Boehringer Ingelheim Vetmedica Recent Development
Table 57. Key Raw Materials Lists
Table 58. Raw Materials Key Suppliers Lists
Table 59. Equine Influenza Vaccine Customers List
Table 60. Equine Influenza Vaccine Distributors List
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Influenza Vaccine Product Picture
Figure 2. Global Equine Influenza Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Equine Influenza Vaccine Market Size 2017-2028 (US$ Million)
Figure 4. Global Equine Influenza Vaccine Sales 2017-2028 (K Doses)
Figure 5. United States Equine Influenza Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Equine Influenza Vaccine Market Size 2017-2028 (US$ Million)
Figure 7. United States Equine Influenza Vaccine Sales 2017-2028 (K Doses)
Figure 8. United States Equine Influenza Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Equine Influenza Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Equine Influenza Vaccine Report Years Considered
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Equine Influenza Vaccine Market Share by Type in 2022 & 2028
Figure 14. Global Equine Influenza Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Equine Influenza Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Equine Influenza Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 17. Global Equine Influenza Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Equine Influenza Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 19. United States Equine Influenza Vaccine Market Share by Type in 2022 & 2028
Figure 20. United States Equine Influenza Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Equine Influenza Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Equine Influenza Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 23. United States Equine Influenza Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Equine Influenza Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 25. Product Picture of Home
Figure 26. Product Picture of Pet Clinic
Figure 27. Product Picture of Others
Figure 28. Global Equine Influenza Vaccine Market Share by Application in 2022 & 2028
Figure 29. Global Equine Influenza Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Equine Influenza Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Equine Influenza Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 32. Global Equine Influenza Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Equine Influenza Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 34. United States Equine Influenza Vaccine Market Share by Application in 2022 & 2028
Figure 35. United States Equine Influenza Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Equine Influenza Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Equine Influenza Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 38. United States Equine Influenza Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Equine Influenza Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 40. North America Equine Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 41. North America Equine Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Equine Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 45. Europe Equine Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Equine Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 52. Asia-Pacific Equine Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Equine Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 64. Latin America Equine Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Equine Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 69. Middle East & Africa Equine Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Equine Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Equine Influenza Vaccine Value Chain
Figure 74. Equine Influenza Vaccine Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount